Incidence and Outcome of Breast Sarcomas in England (2013–2018): An analysis from the National Cancer Registration and Analysis Service | | 2022 |
Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment | | 2022 |
Lymphedema therapy referral is associated with improved understanding of lymphedema prevention among breast cancer survivors | | |
A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting | | |
Impact of postmastectomy radiation therapy on breast cancer patients according to pathologic nodal status after modern neoadjuvant chemotherapy | | |
Patterns of Care and Utilization of Radiation for Women With Good-Risk Ductal Carcinoma In Situ: A National Cancer Database Analysis | | 2022 |
Survival benefits of primary tumor surgery for synchronous brain metastases: A SEER ‐based population study with propensity‐matched comparative analysis | | |
Reducing rates of chronic breast cancer–related lymphedema with screening and early intervention: an update of recent data | | |
Cost-Effectiveness Analysis of Trastuzumab Deruxtecan versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer in the USA | | |
Serum 25-hydroxyvitamin D and cancer-related fatigue: associations and effects on depression, anxiety, functional capacity and health-related quality of Life in breast cancer survivors during adjuvant endocrine therapy | | 2022 |
ASO Author Reflections: Surgical De-escalation for the Management of Ipsilateral Breast Cancer Recurrence in the Modern Era of Multimodality Treatment | | |
Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery | | |
Modern Management of Chest Wall Recurrences after Mastectomy | | |
Radiation Therapy With Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study | | 2022 |
De-escalating Surgery Among Patients with HER2 + and Triple Negative Breast Cancer | | |
Prognostic factors in patients with primary operable breast cancer (cT1-2N0-1M0) after reconstructive plastic surgery with single-stage reconstruction using endoprosthesis | | 2022 |
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018 | Breast Cancer Research and Treatment | |
Tearing down the barriers to exercise after mastectomy: a qualitative inquiry to facilitate exercise among breast cancer survivors | BMJ Open | 2022 |
Near-maximum rib dose is the most relevant risk factor for ipsilateral spontaneous rib fracture: a dosimetric analysis of breast cancer patients after radiotherapy | Strahlentherapie Und Onkologie | |
Locoregional Management of Breast Cancer Following Neoadjuvant Chemotherapy | Current Breast Cancer Reports | |
The Protective Effects of Influenza Vaccination in Elderly Patients with Breast Cancer in Taiwan: A Real-World Evidence-Based Study | Vaccines | 2022 |
Male Breast Cancer Patient and Surgeon Experience: The Male WhySurg Study | Annals of Surgical Oncology | |
Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients | Annals of Surgical Oncology | |
A Critical Overview of Predictors of Heart Sparing by Deep-Inspiration-Breath-Hold Irradiation in Left-Sided Breast Cancer Patients | Cancers | 2022 |
Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery? | Annals of Surgical Oncology | |
Clinical Significance of Radiologically Detected Small Indeterminate Extra-Mammary Lesions in Breast Cancer Patients | The Journal of Breast Health | 2022 |
Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement | Annals of Surgical Oncology | |
Is there a window of opportunity to optimize trastuzumab cardiac monitoring? | World Journal of Cardiology | 2022 |
UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer | Clinical and Translational Medicine | 2022 |
Margin Management and Adjuvant Therapy for Phyllodes Tumors: Practice Patterns of the American Society of Breast Surgeons Members | Annals of Surgical Oncology | |
Sentinel Lymph Node Biopsy by Lymphatic Flare Technique: a Feasibility Study—“The FLAIR Is in the FLARE” | Indian Journal of Surgical Oncology | |
A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence | Annals of Surgical Oncology | |
Usefulness of Hounsfield Units and the Serum Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Patients with Breast Cancer | Cancers | 2022 |
Comparing oncoplastic breast reduction with immediate symmetry surgery to standard breast reduction surgery: Are postoperative complications worse? | Journal of Surgical Oncology | |
Chest wall resection for breast cancer: 21st century Mayo clinic experience | Journal of Surgical Oncology | |
Post-mastectomy radiotherapy bolus associated complications in patients who underwent two-stage breast reconstruction | Advances in Radiation Oncology | 2022 |
Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer | Annals of Surgical Oncology | |
Immunotherapy for triple negative breast cancer: How can pathologic responses to experimental drugs in early-stage disease be enhanced? | Expert Opinion on Investigational Drugs | |
Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclines | Cancer Medicine | |
Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration | Annals of Surgical Oncology | |
Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy | Breast Cancer Research and Treatment | 2022 |
Update on Sentinel Node Pathology in Breast Cancer | Seminars in Diagnostic Pathology | 2022 |
The increasing importance of pathology in modern clinical trial conduct: OlympiA as a case in point | Pathology | 2022 |
Comparison of Heart and Lung Doses According to Tumor Bed Boost Techniques in Early-Stage Left-Sided Breast Cancer: Simultaneous Integrated Boost versus Sequential Boost | Medicina (Lithuania) | 2022 |
Gynecological Cancer and Breast Cancer | | 2022 |
Lymphedema in Cancer Patients | | 2022 |
Aspectos clínicos y terapéuticos del carcinoma de mama metastásico triple negativo | Anales Médicos De La Asociación Médica Del Centro Médico ABC | 2022 |
Tailoring the Omission of Radiotherapy for Early-Stage Breast Cancer Based on Tumor Biology | Seminars in Radiation Oncology | 2022 |
The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy | Breast Cancer Research and Treatment | |
Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience | Cancer Medicine | |
Evolving Role of Risk Tailored Therapy in Early Stage HER2-Positive Breast Cancer: A Canadian Perspective | Current Oncology | 2022 |
Metaplastic Matrix-Producing Carcinoma and Apocrine Lobular Carcinoma In Situ Associated with Microglandular Adenosis: A Unique Case Report | Diagnostics | 2022 |
Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers | PLoS ONE | 2022 |
Perioperative HER2 targeted treatment in early stage HER2-positive breast cancer | Therapeutic Advances in Medical Oncology | 2022 |
Breast cancer | | 2023 |
Management of triple negative breast cancer in a centenarian | Cancer Reports | |
Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC) | Breast Cancer | |
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer | Cancers | 2022 |
Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy | Breast Cancer Research and Treatment | |
SFRP4 and CDX1 Are Predictive Genes for Extragastric Recurrence of Early Gastric Cancer after Curative Resection | Journal of Clinical Medicine | 2022 |
What Is the Best Imaging Modality for Breast Cancer Detection in Women with a Personal History? | Academic Radiology | 2022 |
T-DM1 after Pertuzumab plus Trastuzumab: Treatment Sequence-Induced Selection Bias in HER2-Positive Metastatic Breast Cancer | Cancers | 2022 |
The morphologic spectrum of lobular carcinoma in situ (LCIS) observations on clinical significance, management implications and diagnostic pitfalls of classic, florid and pleomorphic LCIS. | Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin | 2022 |
A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer. | Cancer | 2022 |
Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib. | Annals of Oncology | 2022 |
Culturally Sensitive Recommendations for the Clinical Pharmacist to Engage the Arab American Patient | JACCP Journal of the American College of Clinical Pharmacy | |
Real world incidence and management of adverse events in patients with HR+, HER2- metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting. | Current Medical Research and Opinion | 2022 |
Bone Health Considerations in Breast Cancer. | Seminars in Oncology Nursing | 2022 |
Treatment Patterns in Women Age 80 and Over with DCIS: A Report from the National Cancer Database | Clinical Breast Cancer | 2022 |
ASO Author Reflections: Axillary Management in Mastectomy Patients with Limited Nodal Burden. | Annals of Surgical Oncology | 2022 |
Pharmacological Prevention and Management of Skeletal-Related Events and Bone Loss in Individuals with Cancer. | Seminars in Oncology Nursing | 2022 |
Surgical Treatment of de novo Metastatic Breast Cancer | Current Breast Cancer Reports | |
The role of physics in modern radiotherapy: Current advances and developments | | 2022 |
ASO Author Reflections: Undertreatment of Early-Stage Breast Cancer in Elderly Women Undergoing Lumpectomy Without Radiotherapy Increases the Risk of Locoregional Recurrence. | Annals of Surgical Oncology | 2022 |
Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database. | Annals of Surgical Oncology | 2022 |
Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy. | Annals of Surgical Oncology | 2022 |
Synthetic contrast-enhanced computed tomography generation using a deep convolutional neural network for cardiac substructure delineation in breast cancer radiation therapy: a feasibility study. | Radiation Oncology | 2022 |
Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010-2017. | Breast Cancer Research and Treatment | 2022 |
Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years. | Breast Cancer Research and Treatment | 2022 |
table_1.PDF | | 2018 |
Data_Sheet_1.pdf | | 2019 |
Table_1.XLS | | 2018 |
Breast-conserving surgery with whole breast radiation therapy has a subsequent lower mood disorder incidence rate than total mastectomy in early-stage breast cancer patients: a nationwide population-based longitudinal study. | Breast Cancer Research and Treatment | 2022 |
ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla. | Annals of Surgical Oncology | 2022 |
Partial Breast Re-Irradiation for Patients with Ipsilateral Breast Tumor Recurrence After Initial Treatment with Breast Conservation for Early Stage Breast Cancer. | Practical Radiation Oncology | 2022 |
Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern. | Frontiers in Oncology | 2022 |
A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles. | Breast Cancer Research and Treatment | 2022 |
Adjuvant Versus Neoadjuvant Systemic Therapy | | 2022 |
Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea. | Drugs - Real World Outcomes | 2021 |
Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review. | Frontiers in Pharmacology | 2021 |
A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer | Scientific Reports | 2021 |
Imaging of the Axilla and Approaches to Node-Negative Versus Node-Positive Disease at Presentation | | 2022 |
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction. | Current Oncology Reports | 2022 |
Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer. | Npj Breast Cancer | 2022 |
Therapeutic and immunomodulatory potential of pazopanib in malignant phyllodes tumor. | Npj Breast Cancer | 2022 |
Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. | Scientific Reports | 2022 |
Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data. | Pharmacogenomics Journal | 2022 |
The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment. | Npj Breast Cancer | 2022 |
Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016. | Breast Cancer Research and Treatment | 2022 |
Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings. | Npj Breast Cancer | 2022 |